<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
55154-4739-8
</NDCCode>
<PackageDescription>
1 CARTON in 1 BAG (55154-4739-8) > 1 SYRINGE, PLASTIC in 1 CARTON > 4 mL in 1 SYRINGE, PLASTIC
</PackageDescription>
<NDC11Code>
55154-4739-08
</NDC11Code>
<ProductNDC>
55154-4739
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Verapamil Hydrochloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Verapamil Hydrochloride
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20110325
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA075136
</ApplicationNumber>
<LabelerName>
Cardinal Health
</LabelerName>
<SubstanceName>
VERAPAMIL HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
2.5
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-03-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>